Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes

Published:2020-05-31 Issue:9 Volume:22 Page:1696-1700
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Prattichizzo Francesco¹^ORCID,Giuliani Angelica²,Sabbatinelli Jacopo²^ORCID,Matacchione Giulia²,Ramini Deborah²,Bonfigli Anna Rita³,Rippo Maria Rita²,Candia Paola¹,Procopio Antonio Domenico²⁴,Olivieri Fabiola²⁴,Ceriello Antonio¹

Affiliation:

1. IRCCS MultiMedica Milan Italy

2. Department of Clinical and Molecular Sciences (DISCLIMO)Università Politecnica delle Marche Ancona Italy

3. Scientific DirectionIRCCS INRCA, National Institute Ancona Italy

4. Center of Clinical Pathology and Innovative TherapyIRCCS INRCA Ancona Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14081

Reference18 articles.

1. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

2. How Common Is Residual Inflammatory Risk?

3. Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond

4. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

5. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients;Clinical Diabetes and Endocrinology;2024-08-31

2. DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes;Cardiovascular Diabetology;2024-07-13

3. Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes;Diabetology & Metabolic Syndrome;2024-06-25

4. Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine;Ageing Research Reviews;2024-04

5. Long-COVID-19 autonomic dysfunction: An integrated view in the framework of inflammaging;Mechanisms of Ageing and Development;2024-04